showed a trendp = 0.026
Patients of the N-ABS group showed a trend of better recovery of follow-up LV EF and WMSI than the ABS group (LV EF, 59.0 ± 3.0% vs. 54.2 ± 5.0%, p = 0.026; WMSI, 1.08 ± 0.14 vs. 1.20 ± 0.28, p = 0.304).
Patients of the N-ABS group showed a trend of better recovery of follow-up LV EF and WMSI than the ABS group (LV EF, 59.0 ± 3.0% vs. 54.2 ± 5.0%, p = 0.026; WMSI, 1.08 ± 0.14 vs. 1.20 ± 0.28, p = 0.304).
3.85 ± 0.58 mmol/L, p = 0.048) with marginal significance in the N-ABS group than in the ABS group.